Skinvisible (SKVI) Intangibles (2010 - 2026)
Skinvisible's (SKVI) quarterly Intangibles came in at $90033.0 in Q2 2026, down 18.35% year-over-year from $110273.0 in Q2 2025, and down 5.26% quarter-over-quarter from $95029.0 in Q1 2026.
Powered by 
Analysis
Skinvisible (SKVI) Intangibles (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Intangibles across 17 years of filings, most recently posting $90033.0 for Q2 2026.
- In Q2 2026, Intangibles fell 18.35% year-over-year to $90033.0; the TTM figure through Jun 2026 stood at $90033.0 (down 18.35% YoY), while the FY2025 annual figure was $100036.0, down 13.9% from the prior year.
- Intangibles came in at $90033.0 for Q2 2026 at Skinvisible, down from $95029.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $148462.0 in Q1 2022 to a low of $90033.0 in Q2 2026.
- Average Intangibles over 5 years is $122235.6, with a median of $124945.0 recorded in 2024.
- Year-over-year, Intangibles slumped 48.41% in 2022 and declined 6.24% in 2023.
- Over 5 years, Intangibles stood at $136847.0 in 2022, then fell by 6.9% to $127409.0 in 2023, then fell by 8.81% to $116189.0 in 2024, then fell by 13.9% to $100036.0 in 2025, then retreated by 10.0% to $90033.0 in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $90033.0 in Q2 2026, $95029.0 in Q1 2026, and $100036.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 47.05 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 30.64 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 63.28 Mn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 103.20 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 90,033.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90,033.00 |
| Mar 31, 2026 | 95,029.00 |
| Dec 31, 2025 | 100,036.00 |
| Sep 30, 2025 | 105,154.00 |
| Jun 30, 2025 | 110,273.00 |
| Mar 31, 2025 | 111,249.00 |
| Dec 31, 2024 | 116,189.00 |
| Sep 30, 2024 | 121,239.00 |
| Jun 30, 2024 | 127,176.00 |
| Mar 31, 2024 | 122,714.00 |
| Dec 31, 2023 | 127,409.00 |
| Sep 30, 2023 | 132,156.00 |
| Jun 30, 2023 | 136,697.00 |
| Mar 31, 2023 | 132,728.00 |
| Dec 31, 2022 | 136,847.00 |
| Sep 30, 2022 | 141,060.00 |
| Jun 30, 2022 | 145,789.00 |
| Mar 31, 2022 | 148,462.00 |
| Dec 31, 2021 | 153,591.00 |
| Sep 30, 2021 | 157,750.00 |